CpG stimulation of primary mouse B cells is blocked by inhibitory oligodeoxyribonucleotides at a site proximal to NF-κB activation

Antisense and Nucleic Acid Drug Development

Volumn 11, Issue 4, 2001, Pages 247-256

  Lenert, P ^a   Stunz, L ^a,b   Yi, A K ^a   Krieg, A M ^a,b,c   Ashman, R F ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; GLIOTOXIN; I KAPPA B; I KAPPA B ALPHA; I KAPPA B BETA; IMMUNOGLOBULIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITORY OLIGODEOXYRIBONUCLEOTIDE DERIVATIVE; INHIBITORY PHOSPHOROTHIOIC ACID CPG OLIGODEOXYRIBONUCLEOTIDE; INTERLEUKIN 6; OLIGODEOXYRIBONUCLEOTIDE; PHOSPHOROTHIOIC ACID; PHOSPHOROTHIOIC ACID CPG OLIGODEOXYRIBONUCLEOTIDE; PHOSPHOROTHIOIC ACID DERIVATIVE; PHOSPHOTRANSFERASE; PROTEIN P105; PROTEIN P50; STIMULATORY PHOSPHOROTHIOIC ACID CPG OLIGODEOXYRIBONUCLEOTIDE; SYNAPTOTAGMIN; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; B LYMPHOCYTE ACTIVATION; BINDING SITE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; CPG ISLAND; CYTOKINE PRODUCTION; DNA BINDING; MOUSE; NONHUMAN; NUCLEOTIDE METABOLISM; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

EID: 0034856551     PISSN: 10872906     EISSN: None     Source Type: Journal    
DOI: 10.1089/108729001317022241     Document Type: Article

References (53)

1. Phosphatidylinositol 3-kinase and NF-kappaB/Rel are at the divergence of CD40-mediated proliferation and survival pathways
2. The NF-κB and IκB proteins: New discoveries and insights
3. Antiproliferative activity of G-rich oligonucleotides correlates with protein binding
4. Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-κB transcription factor
5. Embryonic lethality and liver degeneration in mice lacking the Re1A component of NF-κB
6. Formation of G-tetrad and higher order structures correlates with biological activity of the Re1A (NF-κB p65) "antisense" oligonucleotide
7. Cross-linking CD40 on B cells rapidly activates nuclear factor-kappa
8. Nuclear factor (NF)-κB2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses
9. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei
10. Constitutive nuclear translocation of NF-κB in B cells in the absence of IkB degradation
11. The c-rel proto-oncogene product repress NF-kB p65-mediated transcriptional activation of the long terminal repeat of type 1 human immunodeficiency virus
12. NF-κB Rel-A-deficient lymphocytes: Normal development of T ceils and B cells, impaired production of IgA and lgG1 and reduced proliferative responses
13. A switch in distinct IκBα degradation mechanisms mediates constitutive NF-κB activation in mature B cells
14. Induction of the transcription factors NF-κB, AP-1 and NF-AT during B cell stimulation through the CD40 receptor
15. The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-κB-mediated inhibition
16. NF-κB and Rel proteins: Evolutionary conserved mediators of immune responses
17. The subunit composition of NF-kappa B complexes changes during B cell development
18. B lymphocytes differentially use the Rel and nuclear factor kappaB1 (NF-kappaBl) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells
19. In vitro inhibition of murine IFNγ production by phosphorothioate deoxyguanosine oligomers
20. A Toll-like receptor recognizes bacterial DNA
21. Apoptosis in splenic B lymphocytes: Regulation by protein kinase C and IL-4
22. Phosphorylation meets ubiquitination: The control of NF-κB activity
23. Binding of oligoguanylate to scavenger receptors is required for oligodeoxyribonucleotides to augment NK cell activity and induce IFN
24. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression
25. Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs
26. CpG motifs in bacterial DNA trigger direct B cell activation
27. Sequential induction of NF-κB/Rel family proteins during B-cell terminal differentiation
28. Inducible nuclear expression of NF-κB in primary B cells stimulated through the surface Ig receptor
29. Signal transduction: Catalysis by a multiprotein IkappaB kinase complex
30. Transcription factors NF-IL-6 and NF-κB synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8
31. RelB nuclear translocation regulates B cell MHC molecule, CD40 expression, and antigen-presenting cell function
32. The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-κB
33. Inhibition of murine macrophage IL-12 production by natural and synthetic DNA
34. The p65 subunit of NF-kappa B regulates I kappa B by two distinct mechanisms
35. Multiple nuclear factors interact with the immunoglobulin enhancer sequences
36. Inducibility of the immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism
37. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses
38. B cells lacking Re1B are defective in proliferative responses, but undergo normal B cell maturation to Ig secretion and Ig class switching
39. Positive and negative regulatory elements contribute to CpG-oligonucleotide-mediated regulation of human Il-6 gene expression
40. Inhibition of CD28 expression by oligonucleotide decoys to the regulatory element in exon 1 of the CD28 gene
41. Oligonucleotide-mediated inhibition of CD28 expression induces human T cell hyporesponsiveness and manifests impaired contact hypersensitivity in mice
42. Simultaneous staining of ribonucleic acid and deoxyribonucleic acid in unfixed cells using acridine orange in a flow cytometric system
43. c-Rel is essential for B lymphocyte survival and cell cycle progression
44. Prevention of etoposide-induced apoptosis by proteasome inhibitors in a human leukemic cell line but not in fresh acute leukemia blasts. A differential role of NF-κB activation
45. The Influence of DNA sequence on the immunostimulatory properties of plasmid DNA vectors
46. Primary B cells essentially lack constitutve NF-κB activity
47. CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry
48. CpG DNA rescue of murine B lymphoma cells from anti-IgM-induced growth arrest and programmed cell death is associated with increased expression of c-myc and bcl-xl
49. CpG DNA rescue from anti-IgM-induced WEHI-231 B lymphoma apoptosis via modulation of IκBα and IκBβ and sustained activation of nuclear factor-κB/c-Rel
50. CpG DNA rescue B cells from apoptosis by activating NF-κB and preventing mitochondrial membrane potential disruption via a chloroquine-sensitive pathway
51. CpG motifs in bacterial DNA activate leukocytes through the pH-dependent generation of reactive oxygen species
52. Requirements for effective inhibition of immunostimulatory CpG motifs by neutralizing motifs